Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1,1600
Trial Sponsor
Clinical Trial Start Date
2005
0Primary Completion Date
2006
0Study Completion Date
2006
0Clinical Trial Study Type
Interventional0
Intervention Type
Dietary Supplement0
Interventional Trial Phase
Not Applicable0
Official Name
RCT of Supplemented Docosahexaenoic Acid and Gross Motor Development Milestones in Healthy Infants0
Last Updated
February 8, 2008
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Quadruple0
Masked Party
Participant0
Outcomes Assessor0
Investigator0
Care Provider0
Other attributes
Intervention Treatment
Docosahexaenoic acid (DHA)0
Study summary
To examine whether daily supplement of docosahexaenoic acid throughout the first year of life may speed up the achievement of gross motor development milestones in healthy infants, a total of 1160 healthy infants randomly allocated to receive throughout the first year of life daily oral supplement of vitamin D3 (400 IU) plus docosahexaenoic acid (20 mg) or vitamin D3 (400 IU) alone. Primary outcome measure: time of achieving gross motor development milestones. Secondary outcome measure: time of achieving early fine motor development milestones and language.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
